BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 24873995)

  • 1. Cost-effectiveness of FDG-PET/CT for cytologically indeterminate thyroid nodules: a decision analytic approach.
    Vriens D; Adang EM; Netea-Maier RT; Smit JW; de Wilt JH; Oyen WJ; de Geus-Oei LF
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3263-74. PubMed ID: 24873995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis.
    Khiewvan B; Nopmaneejumruslers C; Pusuwan P; Tuchinda P; Tojinda N; Ubolnuch K
    J Med Assoc Thai; 2013 Oct; 96(10):1350-64. PubMed ID: 24350419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?
    Deandreis D; Al Ghuzlan A; Auperin A; Vielh P; Caillou B; Chami L; Lumbroso J; Travagli JP; Hartl D; Baudin E; Schlumberger M; Leboulleux S
    Thyroid; 2012 Feb; 22(2):165-72. PubMed ID: 22257371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis of routine surveillance imaging of patients with diffuse large B-cell lymphoma in first remission.
    Huntington SF; Svoboda J; Doshi JA
    J Clin Oncol; 2015 May; 33(13):1467-74. PubMed ID: 25823735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Diagnostics and [
    de Koster EJ; Morreau H; Bleumink GS; van Engen-van Grunsven ACH; de Geus-Oei LF; Links TP; Wakelkamp IMMJ; Oyen WJG; Vriens D
    Thyroid; 2024 Jan; 34(1):41-53. PubMed ID: 38009209
    [No Abstract]   [Full Text] [Related]  

  • 6. Is there a role for fluorodeoxyglucose positron emission tomography/computed tomography in cytologically indeterminate thyroid nodules?
    Hales NW; Krempl GA; Medina JE
    Am J Otolaryngol; 2008; 29(2):113-8. PubMed ID: 18314022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [
    de Koster EJ; de Geus-Oei LF; Brouwers AH; van Dam EWCM; Dijkhorst-Oei LT; van Engen-van Grunsven ACH; van den Hout WB; Klooker TK; Netea-Maier RT; Snel M; Oyen WJG; Vriens D;
    Eur J Nucl Med Mol Imaging; 2022 May; 49(6):1970-1984. PubMed ID: 34981165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid nodules with indeterminate cytology: prospective comparison between 18F-FDG-PET/CT, multiparametric neck ultrasonography, 99mTc-MIBI scintigraphy and histology.
    Piccardo A; Puntoni M; Treglia G; Foppiani L; Bertagna F; Paparo F; Massollo M; Dib B; Paone G; Arlandini A; Catrambone U; Casazza S; Pastorino A; Cabria M; Giovanella L
    Eur J Endocrinol; 2016 May; 174(5):693-703. PubMed ID: 26966173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of a novel molecular test for cytologically indeterminate thyroid nodules.
    Li H; Robinson KA; Anton B; Saldanha IJ; Ladenson PW
    J Clin Endocrinol Metab; 2011 Nov; 96(11):E1719-26. PubMed ID: 21865367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18FDG-positron emission tomography/computed tomography (PET/CT) scanning in thyroid nodules with nondiagnostic cytology.
    Giovanella L; Suriano S; Maffioli M; Ceriani L
    Clin Endocrinol (Oxf); 2011 May; 74(5):644-8. PubMed ID: 21470288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
    Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exclusion of malignancy in thyroid nodules with indeterminate fine-needle aspiration cytology after negative 18F-fluorodeoxyglucose positron emission tomography: interim analysis.
    Traugott AL; Dehdashti F; Trinkaus K; Cohen M; Fialkowski E; Quayle F; Hussain H; Davila R; Ylagan L; Moley JF
    World J Surg; 2010 Jun; 34(6):1247-53. PubMed ID: 20140435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
    Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
    World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules.
    Merten MM; Castro MR; Zhang J; Durski J; Ryder M
    Thyroid; 2017 Jan; 27(1):95-102. PubMed ID: 27762671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrasound stratification of the FDG-avid thyroid nodule.
    Beech P; Lavender I; Jong I; Soo G; Ramdave S; Chong A; Nandurkar D
    Clin Radiol; 2016 Feb; 71(2):164-9. PubMed ID: 26683088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indeterminate thyroid cytology in an iodine-deficient population: Prevalence, operation rate, risk of malignancy anddiagnostic value of thyroid scintigraphy and
    Almasi CE; Frandsen AP; Erentaite D; Duch K; Zacho HD
    Hell J Nucl Med; 2023; 26(1):2-8. PubMed ID: 37031417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative evaluation of thyroid nodules with 18FDG-PET/CT.
    Mitchell JC; Grant F; Evenson AR; Parker JA; Hasselgren PO; Parangi S
    Surgery; 2005 Dec; 138(6):1166-74; discussion 1174-5. PubMed ID: 16360405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial.
    de Koster EJ; Vriens D; van Aken MO; Dijkhorst-Oei LT; Oyen WJG; Peeters RP; Schepers A; de Geus-Oei LF; van den Hout WB;
    Eur J Nucl Med Mol Imaging; 2022 Aug; 49(10):3452-3469. PubMed ID: 35435497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of alternative management strategies for patients with solitary pulmonary nodules.
    Gould MK; Sanders GD; Barnett PG; Rydzak CE; Maclean CC; McClellan MB; Owens DK
    Ann Intern Med; 2003 May; 138(9):724-35. PubMed ID: 12729427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preoperative evaluation of cytologically indeterminate thyroid nodules with 18F-FDG PET].
    Sebastianes FM; Cerci JJ; Soares JĂșnior J; Zanoni PH; Tomimori EK; Camargo RY; Meneghetti JC; Pereira MA
    Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1176-83. PubMed ID: 19082307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.